Aspen Investment Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$408K Sell
9,557
-1,572
-14% -$85.4K 0.11% 145
2026
Q1
$698K Sell
11,129
-565
-5% -$45.2K 0.21% 105
2025
Q4
$1.11M Buy
11,694
+480
+4% +$47.1K 0.34% 88
2025
Q3
$1.09M Buy
11,214
+740
+7% +$76.6K 0.42% 70
2025
Q2
$1.13M Buy
10,474
+1,774
+20% +$179K 0.47% 63
2025
Q1
$878K Buy
8,700
+1,497
+21% +$151K 0.4% 71
2024
Q4
$643K Buy
7,203
+35
+0.5% +$3.08K 0.3% 84
2024
Q3
$601K Buy
7,168
+895
+14% +$70.6K 0.28% 88
2024
Q2
$483K Buy
6,273
+751
+14% +$55K 0.24% 99
2024
Q1
$378K Buy
5,522
+687
+14% +$44.2K 0.19% 121
2023
Q4
$280K Hold
4,835
0.16% 123
2023
Q3
$255K Buy
4,835
+720
+17% +$37.8K 0.15% 127
2023
Q2
$223K Buy
+4,115
New +$215K 0.13% 128
2020
Q1
Sell
-7,975
Closed -$361K 106
2019
Q4
$361K Buy
7,975
+500
+7% +$20.9K 0.23% 94
2019
Q3
$304K Buy
7,475
+500
+7% +$21.2K 0.2% 103
2019
Q2
$300K Buy
6,975
+1,000
+17% +$38.5K 0.2% 107
2019
Q1
$229K Buy
+5,975
New +$228K 0.16% 125

Other funds holding BSX

Aspen Investment Management's BSX Position: Q2 2026 in Review

Aspen Investment Management reduced its Boston Scientific (BSX) stake by 14% in Q2 2026, selling an estimated $85.4K and leaving 9,557 shares worth $408K. The position accounts for 0.11% of the portfolio, ranked #145.

Aspen Investment Management first reported a position in BSX in Q1 2019 and has held it in 17 quarters since. The position peaked at $1.13M in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Aspen Investment Management held 9,557 shares of Boston Scientific worth $408K as of Q2 2026.
  • Aspen Investment Management sold 1,572 Boston Scientific shares in Q2 2026, an estimated $85.4K.
  • Boston Scientific made up 0.11% of Aspen Investment Management's portfolio in Q2 2026, its #145 holding.
  • Aspen Investment Management first reported a position in Boston Scientific in Q1 2019 and has held it in 17 quarters since.
  • Aspen Investment Management's Boston Scientific position peaked at $1.13M in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Aspen Investment Management's 13F filing for Q2 2026, filed 17 Jul 2026.